Jim Tananbaum is the CEO and founder of Foresite Capital. He started in 2011 as a health care private firm that is passionate about identifying healthcare leaders that emerge, it then aided in growing to profitability by supplying capital, networks, and the necessary information. Check out LinkedIn for more info.
Jim Tananbaum also co-founded leading biopharmaceutical companies and health care investment practices, before founding Foresite Capital. He is the founder of GelTex Pharmaceuticals. The latter brought some drugs to the market which cost less than 80 million dollars. Visit LinkedIn Forsite Capital to know more.
Besides, Jim co-founded and was also CEO of Theravance that shares a joint venture with GSK’s respiratory franchise.
Jim has many investments that have significantly improved his experience, which includes being a founding partner of Prospect Venture Partners. In the earlier days of his career, he partnered with Sierra Ventures. While there, he contributed in establishing its healthcare services.
In spite of being such a busy person, Jims spent most of his day with other members of his team. The family is his priority, and the favorite thing that he enjoys a lot is having dinner with his family. If he is not with them, he would be networking with friends.
He says that bringing ideas to life does not only involve capital, but also it requires engaging smartest and persistent leaders in healthcare. The business that he does is about giving these individuals the means to make the scientific discoveries that make the greatest impact on healthcare.
Jim notes that he is a risk taker, especially after spending a lot of time understanding a situation. He has learned that whenever he spends time on due diligence, he is more likely to have multiple returns than a loss. His belief is that the greatest sin is not to invest in the big companies because of fear of losing.
Since he was in high school, Jim has had a great passion for interdisciplinary hard sciences, computer since with healthcare. The former math and electrical engineering student at Yale received his MD and MBA from Harvard. He has had long productive relationships with leading academicians.
Jim has a firm believe that the next critical area of healthcare growth will come from the combination of data science techniques and biotechnology. More details can be found on Crunchbase.
Check out his Facebook page